Publication | Closed Access

Integrating network pharmacology and experimental models to investigate the mechanisms of dihydroartemisinin in preventing NSCLC progression via mTOR/HIF-1α signaling

Network PharmacologySignal TransductionMedicineMechanism Of ActionMtor/hif-1α SignalingPharmacotherapyNsclc ProgressionSystem PharmacologySystems BiologyPharmacology